Safety and efficacy of trisectionectomy for hepatocellular carcinoma

被引：11

作者：

Zhou, Yanming ^{[1
,2
]}

Sui, Chengjun ^{[1
]}

Li, Bin ^{[2
]}

Kan, Tong ^{[1
]}

Yang, Jiamei ^{[1
]}

Wu, Mengchao ^{[1
]}

机构：

[1] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Special Treatment & Liver Transplantat, Shanghai 200438, Peoples R China

[2] Xiamen Univ, Affiliated Hosp 1, Dept Hepatobiliary Pancreato Vasc Surg, Xiamen, Peoples R China

来源：

ANZ JOURNAL OF SURGERY | 2011年 / 81卷 / 12期

关键词：

hepatocellular carcinoma; survival; trisectionectomy; PORTAL-VEIN EMBOLIZATION; LEFT HEPATIC TRISECTIONECTOMY; LIVER RESECTION; RISK-FACTORS; MAJOR LIVER; ARTERIAL CHEMOEMBOLIZATION; ESOPHAGEAL-VARICES; VASCULAR EXCLUSION; TRISEGMENTECTOMY; HEPATECTOMY;

D O I：

10.1111/j.1445-2197.2010.05605.x

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Background: Right or left trisectionectomy represents the most extensive and difficult type of hepatic resection, and carries an unfavourably high morbidity and mortality. This retrospective study aimed to evaluate the safety and efficacy of trisectionectomy for hepatocellular carcinoma (HCC). Methods: From January 2000 to December 2008, 35 patients with HCC were treated with trisectionectomy. The treatment outcomes of these patients were retrospectively analysed. Results: Twenty-three right and 12 left trisectionectomies were performed. The overall operative morbidity and mortality were 42.8% (n = 15) and 2.8% (n = 1), respectively. The 1-, 3-, and 5-year overall survival rates were 82.9%, 51.4% and 23.8%, while the 1-, 3- and 5-year disease-free survival rates were 71.4%, 42.9% and 12.9%, respectively. Conclusions: With careful patient selection and meticulous surgical technique, trisectionectomy can be performed safely and is associated with long-term survival in a subset of patients with HCC.

引用

页码：895 / 899

页数：5

共 47 条

[1] Portal vein embolization: rationale, technique and future prospects [J].